RadNet, Inc. Common Stock
RDNTRadNet, Inc. (RDNT) is a leading provider of outpatient diagnostic imaging services in the United States. Established in 1984, the company operates numerous imaging centers, offering services such as MRI, CT, ultrasound, and mammography. RadNet focuses on delivering high-quality, accessible, and cost-effective imaging care, serving hospitals, outpatient clinics, and physicians. It aims to enhance patient outcomes through advanced technology and integrated care solutions.
Company News
DeepHealth, a subsidiary of RadNet, announced the commercial launch of Reporting Pro, an AI-powered solution that automates radiology reporting by integrating speech recognition, clinical AI findings, measurements, and AI-generated impressions. The platform is designed to address radiologist shortages projected to reach 15% by 2029 in the US and ...
RadNet announced a free webinar on June 13, 2026, featuring leading physicians discussing coronary artery disease, prostate cancer, and lung cancer screening. The event aims to educate the public on early detection and risk factors for three major health conditions affecting American men, leveraging RadNet's diagnostic imaging services and AI-enh...
Ventripoint Diagnostics has achieved multiple validation milestones in early 2026, including submitting its VMS+ 4.0 system to China's NMPA for expedited review, exhibiting at Europe's largest congenital cardiology conference, and establishing commercial partnerships for hospital deployment. The company is capitalizing on a shifting procurement e...
RadNet, Inc. announced a dedicated investor conference call on March 5, 2026, to discuss its recently completed acquisition of Gleamer SAS and its Digital Health strategy. The company reported record fourth quarter 2025 revenue of $547.7 million, representing 14.8% year-over-year growth, and released 2026 financial guidance.
Hospital networks are increasingly adopting AI-enhanced cardiac imaging technologies to reduce costs and improve patient outcomes. The AI medical imaging market is projected to reach nearly $20 billion by 2033, with echocardiography expected to grow to $2.64 billion by 2030. Key players including VentriPoint Diagnostics, Butterfly Network, Tempus...
